Update: Common anticholinergic meds seen to increase dementia risk

________________

Dear read­er,

It’s time for Sharp­Brains e‑newsletter dis­cussing the lat­est research and inno­va­tions to help pro­mote brain health, open­ing in this occa­sion with a large and wor­ry­ing study track­ing the long-term neur­al impact of com­mon­ly pre­scribed medications.

New brain research:

• First, do no harm? Com­mon anti­cholin­er­gic meds seen to increase demen­tia risk
• …which is one of the many rea­sons why these 10 high­lights from the 2019 Sharp­Brains Vir­tu­al Sum­mit are so impor­tant to shape a bet­ter sys­tem and future
• New study rein­forces the impor­tance of walk­ing through forests for men­tal and gen­er­al health
• AARP: A major­i­ty of Amer­i­cans believe dietary sup­ple­ments improve brain health, despite the lack of evidence

New brain technology:

• The Ontario Brain Insti­tute (OBI) announces six new ONtre­pre­neurs work­ing at the fron­tier of applied neurotech
• Mon­i­tor­ing the body’s elec­tri­cal sig­nalling to enhance brain health
• Few wear­able neu­rotech­nolo­gies have been direct­ly test­ed by high-qual­i­ty, peer-reviewed research

New brain thinking:

• Watch all Record­ings from the 2019 Sharp­Brains Vir­tu­al Summit
• July 9th in Toron­to, Cana­da: Lat­est research find­ings on Neu­ro­plas­tic­i­ty and Neuropsychology
• Kin­dle Count­down Deal to read over the sum­mer (and apply!) a great book on brain health and neuro-fitness
• Peo­ple spent $1.9 bil­lion last year on apps to keep their brains sharp as they age — here’s what actu­al­ly works

Last but not least, here is a fun brain teas­er for the week­end.  What do you see?

Have a great month of July,

The Sharp­Brains Team